Ethical Considerations for Health Technology Policy About Non-Invasive Prenatal Testing via Fetal DNA in Maternal Blood

关于通过母血中胎儿 DNA 进行无创产前检测的卫生技术政策的伦理考量

• 批准号: 305382
• 负责人: Vanstone Meredith
• 金额: $ 6.83万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=305382&lang=en
• 关键词: Constructivist Grounded Theory; Direct-To-Consumer Marketing; Empirical Ethics; Health Policy; Health Technology Assessment; Non-Invasive Prenatal Testing; Prenatal Testing; Qualitative Research; Relational Autonomy

Non-Invasive Prenatal Testing (NIPT) is a new type of test that can identify genetic conditions in a fetus as early as the 8th week of pregnancy. It does this by analyzing small amounts of fetal DNA found in the mother's blood. It is different from existi

非侵入性产前检查（NIPT）是一种新型的测试，可以在怀孕的第8周就确定胎儿的遗传状况。它通过分析在母亲血液中发现的少量胎儿DNA来做到这一点。它不同于现有的